Moderna Says Coronavirus Vaccine's Effectiveness Will Likely Hold Against New SARS-CoV-2 Variants
Moderna Inc (NASDAQ: MRNA) has assured that there is nothing to worry as the world is threatened by the prospect of SARS-CoV-2 mutating to produce new virulent strains.
What happened: The vaccine-induced immunity to Moderna's coronavirus vaccine candidate - mRNA-1273 - is likely to protect against the new strain of SARS-CoV-2 recently described in the UK, the Massachusetts-based company said in a Declaration from late Wednesday with.
Scroll to continue with the content
Microsoft and Redis
Meet the fast and fully managed in-memory data store.
Don't miss the opportunity to hear the unique perspectives from Microsoft and partner specialists and learn more about Azure Cache for Redis.
The company based the deduction on previous data.
Tests of sera from animals and humans vaccinated with mRNA-1273 have been performed against a number of previous variants of SARS-CoV-2, and the vaccine has remained equally effective.
Related Link: Sarepta, Amicus Top Biotech Selects Major Binary Events: Analyst
"The full-length spike protein is 1,273 amino acids long. While newer variants contain several mutations, for example up to 8 amino acid changes in the spike protein of the B1.1.7 strain, these represent less than 1% difference to the spike protein, which is encoded by Moderna's vaccine, "the company stated.
What's next? Moderna plans to run tests to confirm the vaccine's activity against each strain.
The broad spectrum of potential neutralizing antibodies made possible by mRNA-1273 gives confidence that it will also effectively induce neutralizing antibodies against them.
Moderna's vaccine candidate approval from the FDA on December 18, and most recently Health Canada under an interim injunction to vaccinate people aged 18 and over.
See more from Benzinga
Click here for Benzinga option trades
Moderna, Pfizer tests coronavirus vaccine against new strain
The week before biotech: light calendar in an abbreviated week with 1 IPO, 1 FDA decision
© 2020 Benzinga.com. Benzinga does not offer investment advice. All rights reserved.
You should check here to buy the best price guaranteed products.
Top Republicans turn Jan. 6 blame on Pelosi ahead of first riot committee hearing
Elon Musk said it's 'debatable' whether it's worth paying $199 for Tesla's 'Full Self-Driving' subscription
Inside a KKK murder plot: Grab him up, take him to the river
Jailed: Man who threatened to leak businessman's sex videos
Aztec dancers descend on Mexico City's Zocalo
Hailey Bieber Wore a Velvet Dress With Two Thigh-High Leg Slits With Justin for His Art Gallery Auction